This trial is testing whether a collaborative care team can increase the use of two interventions - medication for opioid use disorder and discharge planning for those with opioid use disorder - and improve linkage to follow-up care.
- Opioid Use Disorder
2 Primary · 4 Secondary · Reporting Duration: 30 days
Awards & Highlights
2 Treatment Groups
1 of 2
Substance Use Treatment and Recovery Team (START)
1 of 2
414 Total Participants · 2 Treatment Groups
Primary Treatment: Substance Use Treatment and Recovery Team (START) · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
- Ober, Allison J., Cristina Murray-Krezan, Kimberly Page, Peter D. Friedmann, Karen Chan Osilla, Stephen Ryzewicz, Sergio Huerta, et al.. 2022. “The Substance Use Treatment and Recovery Team (START) Study: Protocol for a Multi-site Randomized Controlled Trial Evaluating an Intervention to Improve Initiation of Medication and Linkage to Post-discharge Care for Hospitalized Patients with Opioid Use Disorder”. Addiction Science & Clinical Practice. Springer Science and Business Media LLC. doi:10.1186/s13722-022-00320-7.
- Itai Danovitch 2021. "Substance Use Treatment and Recovery Team". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05086796.
Frequently Asked Questions
Is the recruitment process currently open for participants in this research?
"Correct. The information present on clinicaltrials.gov attests that this trial, which was initially posted on November 11th 2021, is currently recruiting for 414 individuals from 3 distinct medical centres." - Anonymous Online Contributor
How many participants are there in the current clinical trial?
"A total of 414 qualified individuals must join this medical trial. Patricipants can enlist from the University of New Mexico Hospital in Albuquerque, NM or Baystate Medical Center located in Springfield, MA." - Anonymous Online Contributor
What are the primary goals this clinical experiment seeks to accomplish?
"This 30-day clinical trial will primarily measure the rate of MOUD therapy initiation in hospital. Secondary objectives focus on OUD-specific discharge plans, post-discharge MOUD use and outpatients medical care within a month after leaving the hospital." - Anonymous Online Contributor